Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening (Q40209539)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 13 November 2006

Language	Label	Description	Also known as
English	Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening	scientific article published on 13 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Feng Ge

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yonghu Luo

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Pei Xiong Liew

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Eugene Hung

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

13 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

360

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

150-158

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

The nucleoprotein is required for efficient coronavirus genome replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Hepatitis C virus replicons: potential role for drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Heterologous gene expression from transmissible gastroenteritis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Coronavirus transcription mediated by sequences flanking the transcription consensus sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Potential High-Throughput Assay for Screening Inhibitors of West Nile Virus Replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Development of Dengue virus type 2 replicons capable of prolonged expression in host cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

The severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Identification of severe acute respiratory syndrome in Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Construction and characterization of subgenomic replicons of New York strain of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

The Biology of Coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Development of a standard treatment protocol for severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Feline calicivirus: recovery of wild-type and recombinant viruses after transfection of cRNA or cDNA constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

Characterization of an autonomous subgenomic pestivirus RNA replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of poliovirus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.10.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Subgenomic replicons of the flavivirus Kunjin: construction and applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17098272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2006.10.016

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40209539&oldid=1888739476"